Financial Statements
Bayer Group Consolidated Statements of Recognized Income and Expense
| 3rd Quarter 2005 | 3rd Quarter 2006 | First Nine Months 2005 | First Nine Months 2006 | |
| € million | ||||
| Changes in fair values of hedging instruments and available-for-sale securities, recognized in stockholders’ equity | 40 | (39) | 32 | (51) |
| Actuarial gains/losses on defined benefit obligations for pensions and other post-employment benefits | 34 | (852) | (1,100) | 335 |
| Exchange differences on translation of operations outside the euro zone | 7 | 47 | 686 | (428) |
| Deferred taxes on valuation adjustments, recognized directly in stockholders’ equity | (17) | 353 | 430 | (108) |
| Valuation adjustments recognized directly in stockholders’ equity | 64 | (491) | 48 | (252) |
| Income after taxes | 496 | 320 | 1,553 | 1,372 |
| Total income and expense recognized in the financial statements | 560 | (171) | 1,601 | 1,120 |
| of which attributable to minority interest | 2 | (3) | (6) | (6) |
| of which attributable to Bayer AG stockholders | 558 | (168) | 1,607 | 1,126 |
2005 figures restated



Overview of Sales, Earnings and Financial Position
Statements of Recognized Income and Expense
Bayer Links

Bookmark this page
E-mail this page
Advanced Search

